USA / New 'Biosecure Act' to Target Chinese Biotechs WuXi and BGI
US Congress has highlighted Chinese biotechnology firms, including giants WuXi and BGI, as posing a risk to the country’s national security. PharmaBoardroom takes a look at why the US is…